(INDV) Indivior Ordinary - Performance -53.3% in 12m
Compare INDV with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
55.04%
#9 in Group
Rel. Strength
11.42%
#7086 in Universe
Total Return 12m
-53.27%
#107 in Group
Total Return 5y
1517.86%
#1 in Group
P/E 472
100th Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 0.42%
83th Percentile in Group
12m Total Return: INDV (-53.3%) vs XBI (-12.1%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-19.2% | 9.47% | 151% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
-11.7% | 23% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-1.45% | 26.1% | 39.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-10.9% | 9.64% | 39.3% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
LONN SW Lonza |
-3.29% | 3.72% | 31.6% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.96% | 17.6% | 11.9% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-10.2% | -24.7% | -1.51% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-6.62% | 33.3% | -5.06% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: INDV vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for INDV
Total Return (including Dividends) | INDV | XBI | S&P 500 |
---|---|---|---|
1 Month | -9.31% | -14.90% | -7.04% |
3 Months | -22.30% | -14.51% | -10.88% |
12 Months | -53.27% | -12.11% | 5.72% |
5 Years | 1517.86% | -20.56% | 100.77% |
Trend Score (consistency of price movement) | INDV | XBI | S&P 500 |
1 Month | -81.7% | -85.2% | -76.1% |
3 Months | -67.5% | -87.6% | -86.4% |
12 Months | -69.0% | -24% | 67.8% |
5 Years | 77.2% | -52.8% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #60 | 6.57% | -2.44% |
3 Month | #89 | -9.11% | -12.8% |
12 Month | #107 | -46.8% | -55.8% |
5 Years | #1 | 1,937% | 706% |
FAQs
Does INDV Indivior Ordinary outperforms the market?
No,
over the last 12 months INDV made -53.27%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.11%.
Over the last 3 months INDV made -22.30%, while XBI made -14.51%.
Over the last 3 months INDV made -22.30%, while XBI made -14.51%.
Performance Comparison INDV vs Indeces and Sectors
INDV vs. Indices INDV is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.31% | -2.27% | 20.5% | -59.0% |
US NASDAQ 100 | QQQ | -1.82% | -1.45% | 20.5% | -56.9% |
US Dow Jones Industrial 30 | DIA | -4.21% | -4.14% | 18.5% | -60.0% |
German DAX 40 | DAX | -14.8% | -1.26% | 1.87% | -72.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | -9.31% | -1.56% | 15.6% | -61.2% |
Hongkong Hang Seng | HSI | -9.98% | 1.84% | 19.1% | -69.4% |
India NIFTY 50 | INDA | -6.32% | -12.7% | 21.0% | -54.0% |
Brasil Bovespa | EWZ | -6.82% | -3.03% | 20.1% | -42.3% |
INDV vs. Sectors INDV is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.12% | -1.73% | 12.3% | -66.5% |
Consumer Discretionary | XLY | -0.72% | -3.09% | 18.2% | -60.6% |
Consumer Staples | XLP | -7.57% | -9.20% | 12.8% | -65.8% |
Energy | XLE | -3.27% | 2.61% | 21.5% | -40.5% |
Financial | XLF | -5.02% | -4.44% | 12.5% | -72.6% |
Health Care | XLV | -4.72% | -2.53% | 21.6% | -53.1% |
Industrial | XLI | -4.81% | -3.34% | 21.1% | -57.2% |
Materials | XLB | -5.81% | -1.87% | 27.9% | -45.3% |
Real Estate | XLRE | -8.06% | -4.32% | 20.7% | -67.6% |
Technology | XLK | -1.62% | 0.52% | 26.5% | -50.1% |
Utilities | XLU | -7.83% | -7.20% | 16.2% | -79.7% |
Aerospace & Defense | XAR | -6.97% | -8.70% | 11.0% | -76.4% |
Biotech | XBI | -6.83% | 5.59% | 36.4% | -41.2% |
Homebuilder | XHB | -1.70% | -0.10% | 39.9% | -41.6% |
Retail | XRT | -2.07% | -3.56% | 27.7% | -46.3% |